Non-electric Intravenous Infusion Pump Market Size & Share 2026-2035

Non-electric Intravenous Infusion Pump Market Size

The global non-electric intravenous infusion pump market was valued at USD 650 million in 2025. The market is expected to grow from USD 681.9 million in 2026 to USD 1 billion in 2035, growing at a CAGR of 4.7% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market growth is attributed to the rising prevalence of chronic conditions, the increasing number of people undergoing surgical procedures, and the surging demand for low-cost alternatives to electronic pumps, among others. Non-electric intravenous infusion pumps are small, disposable, or reusable devices intended to administer fluids, analgesics, antibiotics, and other drugs in a controlled manner without using electricity or batteries.

The key players in the non-electric intravenous infusion pump market are AVANOS, B. Braun, Baxter, VYGON, and NIPRO. These players compete in the market through incremental innovation, expanded distribution channels, and the addition of elastomeric pumps for pain management, chemotherapy, and antibiotics.
 

The market increased from USD 579.2 million in 2022 to USD 622.5 million in 2024, with a historic growth rate of 3.7%. The market has shown steady expansion in recent years, supported by the shift toward outpatient care models and increasing use of ambulatory infusion therapies.
 

Demand is further reinforced by the growing burden of chronic diseases and the need for continuous or prolonged drug delivery outside traditional inpatient settings. Non-electric infusion pumps are valued for their portability, simplicity of use, and lower maintenance requirements, which make them suitable for home healthcare programs and resource-constrained environments. Additionally, their ability to support early discharge protocols and improve patient mobility has contributed to wider clinical acceptance across surgical centers, oncology clinics, and palliative care settings.

Non-electric Intravenous Infusion Pump Market Trends

The growing preference for home-based treatment is playing an important role in supporting the demand for non-electric intravenous infusion pumps. Healthcare systems are increasingly encouraging early discharge and outpatient management to reduce hospital burden and overall treatment costs, creating a favorable environment for portable infusion solutions.
 

• Non-electric infusion pumps are particularly suited for home healthcare due to their mechanical operation and ease of use. Unlike electronic pumps, they do not require batteries, programming, or frequent technical monitoring, which reduces the burden on caregivers and minimizes the risk of operational errors. Their lightweight and discreet design also allows patients to continue daily activities while receiving therapy, making them widely used for post-operative pain control, long-term antibiotic administration, chemotherapy, and palliative care in home environments.
   
• Additionally, the expansion of home healthcare services and community nursing services has strengthened the adoption of these devices. As healthcare systems focus on value-based care and patient-centered treatment pathways, non-electric infusion pumps are increasingly viewed as cost-effective tools that support continuity of care beyond hospital walls. This increasing integration into home infusion programs is expected to sustain demand and contribute to steady market growth over the coming years.

Non-electric Intravenous Infusion Pump Market Analysis

Based on product type, the non-electric intravenous infusion pump market is segmented into elastomeric infusion pumps and mechanical pumps. The elastomeric infusion pumps segment has asserted its dominance in the market by securing a significant market share of 85.7% in 2025, owing to their simplicity, portability, and reliable continuous drug delivery, which make them widely preferred for ambulatory care, post-operative pain management, and home infusion therapies. The segment is expected to exceed USD 905 million by 2035, growing at a CAGR of 5% during the forecast period.
 

• Elastomeric infusion pumps represent the leading segment within the non-electric intravenous infusion pump market, largely due to their practical design and versatility across care settings. These devices use an elastic balloon reservoir to deliver medications at a controlled and consistent rate, eliminating the need for programming or external power sources. Their lightweight structure and quiet operation make them particularly suitable for ambulatory care and home-based treatment, where patient mobility and ease of use are important.
   
• The mechanical pumps segment was valued at USD 93.1 million in 2025 and is expected to reach USD 129.6 million by 2035. Growth in this segment is supported by their durability, controlled flow mechanisms, and suitability for extended infusion therapies in both hospital and home care settings. Increasing preference for low-maintenance and cost-efficient infusion solutions, particularly in resource-limited environments, is further contributing to steady segment expansion.
   

Based on application, the non-electric intravenous infusion pump market is classified into oncology, pain management, pediatrics/neonatology, diabetes, gastroenterology, and other applications. The oncology segment dominated the market with a revenue share of 35.7% in 2025 and is expected to reach USD 388.9 million by 2035.
 

• The leadership of this segment is largely attributed to the growing use of continuous infusion therapies for chemotherapy, supportive care medications, and pain management in cancer patients. Non-electric infusion pumps are widely preferred in oncology due to their portability and ability to support ambulatory chemotherapy, allowing patients to receive treatment outside inpatient settings. Additionally, the increasing global cancer burden and the expansion of home-based oncology care programs are expected to sustain strong demand for these devices over the coming years.
   
• The pain management segment was valued at USD 182.4 million in 2025 and is expected to grow at a CAGR of 4.2% during the forecast period. Growth is supported by increasing use of elastomeric pumps for post-operative analgesia and regional anesthesia, enabling continuous pain relief while reducing reliance on hospital-based care. The shift toward ambulatory surgical procedures and home recovery pathways is further driving the adoption of non-electric infusion pumps in pain management settings.
   
• The pediatrics/neonatology segment was valued at USD 105.4 million in 2025 and is expected to reach USD 162.6 million by 2035. Demand is driven by the need for precise, low-flow drug delivery in neonatal and pediatric care, where gentle and reliable infusion methods are critical. The simplicity, portability, and reduced technical complexity of non-electric pumps make them well-suited for pediatric wards and home-based care for chronic conditions.
   
• The diabetes segment was valued at USD 70 million in 2025 and is poised to witness growth over the coming years. Adoption is supported by the need for controlled infusion of insulin and adjunct therapies in select clinical and home care settings, particularly for patients requiring continuous delivery. The increasing prevalence of diabetes and the expansion of home-based disease management programs are expected to contribute to gradual segment growth.
   
• The gastroenterology segment was valued at USD 39.7 million in 2025 and is expected to reach USD 62.2 million by 2035. Growth is supported by the use of non-electric infusion pumps for continuous delivery of nutrition, antibiotics, and supportive medications in gastrointestinal disorders. Increasing preference for outpatient and home-based management of chronic GI conditions is further contributing to steady demand within this segment.
   
• The other applications segment includes cardiology, post-operative therapy, and palliative care, where non-electric infusion pumps are used for continuous drug delivery, pain control, and supportive treatment. Growing emphasis on patient comfort, early discharge protocols, and home-based supportive care is expected to drive gradual adoption across these additional clinical areas.
   

Based on end use, the non-electric intravenous infusion pump market is classified into hospitals, ambulatory surgical centers, home care settings, and other end-users. The hospitals segment dominated the market with a revenue share of 45.3% in 2025 and is expected to reach USD 453.3 million within the forecast period.
 

• This dominance is driven by the high volume of surgical procedures, oncology treatments, and inpatient therapies that require reliable infusion support. Hospitals continue to rely on non-electric infusion pumps for post-operative pain management, antibiotic delivery, and ambulatory infusion programs that facilitate early discharge. In addition, established procurement systems, clinical familiarity, and the availability of trained staff further contribute to strong adoption of these devices across hospital settings.
   
• The ambulatory surgical centers segment was valued at USD 198.5 million in 2025 and is expected to reach USD 334.1 million by 2035. Growth is supported by the increasing volume of day-care surgeries and the need for portable infusion solutions that enable effective post-operative pain control and early patient discharge. Non-electric infusion pumps are well-suited for these settings due to their simplicity, mobility, and minimal monitoring requirements, contributing to steady segment expansion.
   
• The home care settings segment was valued at USD 119.1 million in 2025 and is expected to reach USD 192.8 million by 2035, growing at a CAGR of 4.9% during the forecast period. Expansion of home infusion therapy programs and increasing preference for treatment outside hospital environments are key factors supporting segment growth. The ease of use, portability, and low maintenance requirements of non-electric infusion pumps make them well-suited for long-term therapy and recovery in home care settings.
   
• The other end users segment includes rehabilitation centers, specialty clinics, and long-term care facilities, where non-electric infusion pumps are used for ongoing therapy, pain control, and supportive treatment. Increasing demand for continuous care outside acute hospital settings and the need for simple, portable infusion solutions are expected to support steady growth across these facilities.
   

North America Non-electric Intravenous Infusion Pump Market

North America dominated the market, accounting for a market share of 40.8% in 2025.
 

• The U.S. market was valued at USD 231.3 million and USD 237.5 million in 2022 and 2023, respectively. The market size reached USD 253.2 million in 2025, growing from USD 244.5 million in 2024, and is anticipated to grow at a CAGR of 3.8% from 2026 to 2035.
   
• The U.S. holds the largest share in the non-electric intravenous infusion pump market, supported by high surgical volumes, strong adoption of ambulatory infusion therapies, and well-established home healthcare infrastructure. Favorable reimbursement pathways and growing preference for outpatient care continue to reinforce market leadership.
   
• Additionally, the presence of leading manufacturers, widespread clinical familiarity with elastomeric pumps, and increasing use in oncology and pain management programs are further strengthening demand across hospitals, ambulatory centers, and home infusion providers.
   

Europe Non-electric Intravenous Infusion Pump Market

The Europe market accounted for USD 183.3 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Europe represents a significant share of the market, driven by expanding day-care surgery programs, increasing use of elastomeric pumps in post-operative pain management, and a strong focus on cost-effective care delivery. Adoption is further supported by aging populations and well-developed community healthcare services.
   
• Government initiatives aimed at reducing inpatient hospital stays and promoting home-based recovery pathways have also contributed to steady utilization of non-electric infusion devices across surgical and chronic care settings.
   

Asia Pacific Non-electric Intravenous Infusion Pump Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 6% during the forecast period.
 

• The Asia Pacific region is emerging as a key growth area due to rising healthcare investments, increasing surgical procedures, and expanding access to home-based treatment pathways. Growing awareness of ambulatory infusion therapies and improving healthcare infrastructure are contributing to regional market expansion.
   
• Moreover, the large patient population, growing burden of chronic diseases, and gradual shift toward decentralized healthcare delivery are expected to create sustained opportunities for market players across both developed and emerging APAC countries.
   

Latin America Non-electric Intravenous Infusion Pump Market
 

The Latin America market accounted for USD 46 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Latin America accounts for a notable share, with demand primarily driven by the gradual adoption of cost-efficient infusion solutions and expansion of outpatient care services. Healthcare modernization efforts and increasing focus on reducing hospital stays are supporting market development in select countries.
   
• The rising presence of private healthcare providers and improving access to ambulatory surgical centers are also encouraging the use of portable infusion devices, particularly for post-operative and antibiotic therapies.
   

Middle East and Africa Non-electric Intravenous Infusion Pump Market

The Middle East and Africa market accounted for USD 17.6 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The Middle East & Africa region holds a notable share, supported by improving healthcare infrastructure, rising prevalence of chronic diseases, and growing interest in portable infusion devices for hospital and home care settings. Market growth is expected to remain gradual, with adoption concentrated in urban healthcare facilities.
   
• Investments in healthcare capacity expansion, increasing medical tourism in certain Middle Eastern countries, and the need for practical infusion solutions in resource-limited environments are further contributing to steady market uptake.
   

Non-electric Intravenous Infusion Pump Market Share

The global non-electric intravenous infusion pump industry is moderately fragmented, with the presence of several international and regional manufacturers offering elastomeric and mechanically driven infusion systems across hospital, ambulatory, and home care settings. Competition is largely shaped by product reliability, pricing strategies, distribution reach, and clinical familiarity rather than breakthrough technological differentiation, as most devices operate on established mechanical delivery principles.
 

Key players in the market include AVANOS, B. Braun, Baxter, VYGON, and NIPRO which collectively hold approximately 25% of the total market share, supported by their broad infusion therapy portfolios, strong distribution networks, and long-standing relationships with hospitals and home infusion providers. Their established presence across both developed and emerging markets enables consistent product uptake and brand recognition.
 

Other participants, such as NIPRO and Ambu, maintain competitive positions through targeted product offerings, regional expansion strategies, and participation in niche therapeutic areas, including pain management and oncology infusion. Meanwhile, companies like Technoline, Multimedical, Go Medical Industries, and epic primarily serve regional markets, contributing to price competitiveness and expanding access in cost-sensitive healthcare environments.
 

Non-electric Intravenous Infusion Pump Market Companies

A few of the prominent players operating in the non-electric intravenous infusion pump industry include:

• Ambu
• AVANOS
• B. Braun
• Baxter
• epic
• Go Medical Industries
• Multimedical
• NIPRO
• Technoline
• VYGON
   
• AVANOS

AVANOS focuses on elastomeric infusion pump solutions widely used in pain management and post-operative care, offering user-friendly designs that support ambulatory and home infusion therapy. Its emphasis on clinical reliability, patient comfort, and strong presence in acute and outpatient settings helps drive consistent adoption.

• B. Braun

B. Braun leverages its extensive infusion therapy portfolio and global healthcare footprint to deliver high-quality non-electric infusion pumps with strong safety features and flow rate accuracy. The company’s established hospital relationships, integrated infusion solutions, and focus on clinical training reinforce its leadership across diverse care environments.

• VYGON

VYGON differentiates itself through cost-effective elastomeric pump systems and a broad range of disposable infusion devices tailored for surgical, oncology, and home care applications. Its focus on product versatility, ease of use, and strong distribution across Europe and emerging markets supports steady market penetration.
 

Non-electric Intravenous Infusion Pump Industry News

• In February 2023, Vygon announced that it has entered into a strategic partnership with the University Hospital of Wales to revolutionize palliative care for advanced heart failure patients by enabling safe, continuous at‑home infusion treatment. The partnership strengthened Vygon’s market position by demonstrating the real‑world clinical, economic, and operational benefits of its Accufuser elastomeric pump, delivering proven cost savings, reduced nursing workload, improved patient experience, and national‑scale adoption potential.
   

The non-electric intravenous infusion pump market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Elastomeric infusion pumps
• Mechanical pumps

Market, By Application

• Oncology
• Pediatrics/Neonatology
• Pain Management
• Diabetes
• Gastroenterology
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Home care settings
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE